参考文献/References:
[1] De-Greef K,Rolfo C,Russo A,et al.Multisciplinary management of patients with liver metastasis from colorectal cancer[J].World J Gastroenterol,2016,22(32):7215-7225.
[2] 林增海,陆 军,王凯松.槲皮素对5-FU诱导的结直肠癌SW480细胞耐药及自噬调控机制研究[J].陕西中医,2021,42(10):1338-1343.
[3] Hussan H,Zhao J,Badu-Tawiah AK,et al.Utility of machine learning in developing a predictive model for early-age-onset colorectal neoplasia using electronic health records[J].PLoS One,2022,17(3):e0265209.
[4] Jeught K,Xu HC,Li YJ,et al.Drug resistance and new therapies in colorectal cancer[J].World J Gastroenterol,2018,24(34):3834-3848.
[5] 中华人民共和国国家卫生健康委员会.中国结直肠癌诊疗规范(2020年版)[J].中华外科杂志,2020,58(8):561-585.
[6] 李金骁,刘 娜,周民锋,等.电针激活沉默信息调节因子1干预结直肠癌炎癌转化小鼠的机制研究[J].针刺研究,2021,46(12):996-1004.
[7] 刘华缓,曹 誉,肖志鹏,等.丁酸钠对AOM/DSS炎症相关性结直肠癌小鼠模型及其肠道菌群的影响[J].中华肿瘤防治杂志,2021,28(18):1368-1377.
[8] 蒋慧灵,郑倩华,赵 映,等.结直肠扩张法诱导大鼠内脏高敏感模型制作概述[J].中国实验动物学报,2021,29(4):528-534.
[9] 高 珊,柳 清.氧化苦参碱通过调节肠道菌群抑制小鼠结直肠癌的相关研究[J].肿瘤研究与临床,2021,33(9):645-650.
[10] Zeuner A,Todaro M,Stassi G,et al.Colorectal cancer stem cells:From the crypt to the clinic[J].Cell Stem Cell,2014,15(6):692-705.
[11] 艾丁丁,罗伟生,蒋云霞.动物肝纤维化模型建立研究进展[J].陕西医学杂志,2020,49(7):907-909.
[12] 蔡碧莲,文亦磊,罗伟生.大鼠肝纤维化实验动物模型的构建[J].陕西医学杂志,2020,49(6):659-662.
[13] Wang S,Zhang Y,Huang J,et al.TRIM67 Activates p53 to suppress colorectal cancer initiation and progression[J].Cancer Res,2019,79(16):4086-4098.
[14] Taketo MM,Edelmann W.Mouse models of colon cancer[J].Gastroenterology,2009,136(3):780-798.
[15] Mittal VK,Bhullar JS,Jayant K.Animal models of human colorectal cancer:Current status,uses and limitations[J].World J Gastroenterol,2015,21(41):11854-11861.
[16] Thalheimer A,Illert B,Bueter M,et al.Feasibility and limits of an orthotopic human colon cancer model in nude mice[J].Comp Med,2006,56(2):105-109.
[17] 张宇坤,胡汉卿,盛祥宗,等.结直肠肿瘤基础研究中小鼠模型总结与对比[J].中国普外基础与临床杂志,2021,28(6):816-820.
[18] 赵日升,曹 蕾,于 君.无菌鼠模型在结直肠癌研究中的应用[J].中国实验动物学报,2017,25(6):658-662.
[19] 文 宇,张子建,颜世超,等.理想小鼠结直肠癌肝转移模型的建立及研究进展[J].中国普通外科杂志,2019,28(4):484-490.
[20] Tseng W,Leong X,Engleman E.Orthotopic mouse model of colorectal cancer[J].J Vis Exp,2007,10:484.
[21] 戴功建,金黑鹰,夏建国.裸鼠结直肠癌原位移植模型的建立和应用进展[J].实用临床医药杂志,2010,14(5):119-121.
[22] Zhu G,Zhao M,Han Q,et al.Temozolomide and pazopanib combined with FOLFOX regressed a primary colorectal cancer in a patient-derived orthotopic xenograft mouse model[J].Transl Oncol,2020,13(3):100739.
[23] Hu HT,Wang Z,Kim MJ,et al.The establishment of a fast and safe orthotopic colon cancer model using a tissue adhesive technique[J].Cancer Res Treat,2021,53(3):733-743.
[24] Kishimoto H,Momiyama M,Aki R,et al.Development of a clinically-precise mouse model of rectal cancer[J].PLoS One,2013,8(11):e79453.
[25] Bhullar JS,Subhas G,Silberberg B,et al.A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation[J].J Am Coll Surg,2011,213(1):54-61.
[26] Hite N,Klinger A,Hellmers L,et al.An optimal orthotopic mouse model for human colorectal cancer primary tumor growth and spontaneous metastasis[J].Dis Colon Rectum,2018,61(6):698-705.
[27] Chen C,Neumann J,Kuhn F,et al.Establishment of an endoscopy-guided minimally invasive orthotopic mouse model of colorectal cancer[J].Cancers(Basel),2020,12(10):3007.
[28] 陈瑶莉,姜 萌.内镜黏膜隧道肿瘤切除术治疗食管固有肌层黏膜肿瘤疗效研究[J].陕西医学杂志,2020,49(8):991-994.
相似文献/References:
[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(6):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(6):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(6):990.
[4]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[5]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(6):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[6]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(6):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(6):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]张言言,韩 刚,曹 羽,等.同源盒基因10调控胰岛素样生长因子结合蛋白3与肠癌细胞5-氟尿嘧啶抵抗的关系研究[J].陕西医学杂志,2022,51(7):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
ZHANG Yanyan,HAN Gang,CAO Yu,et al.Relationship between regulation of IGFBP3 by HOXD10 and 5-fluorouracil resistance in colorectal cancer cells[J].,2022,51(6):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
[9]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]
[10]李敬楠,白春英,房 芹.赤峰地区结直肠癌相关KRAS和PIK3CA基因多态性及临床意义[J].陕西医学杂志,2022,51(9):1137.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.022]
LI Jingnan,BAI Chunying,FANG Qin.Polymorphisms of KRAS and PIK3CA genes related to colorectal cancer in Chifeng area and their clinical significance[J].,2022,51(6):1137.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.022]